3709 results for «200»

Filter By

3709 results

Tricuspid and mitral: fine tuning diagnosis and results in transcatheter valve management

11 Sep 2025 – From PCR Rio Valves 2025

This session focuses on refining diagnosis and treatment outcomes in transcatheter management of tricuspid and mitral valves. Topics include assessment of pulmonary artery pressure changes post-MitraClip, 3D echocardiographic evaluation of tricuspid regurgitation severity, quantitative improvements in imaging, and insights from single-centre experiences. Additional discussions cover bicaval...

The role of mitral TEER in advanced heart failure

11 Sep 2025 – From PCR Rio Valves 2025

This session delves into the role of mitral transcatheter edge-to-edge repair (TEER) in advanced heart failure patients. Understand the indications for mitral TEER in severe left ventricular dysfunction, prognostic challenges in heart failure with severe mitral regurgitation, and review therapeutic alternatives including the pathway from TEER...

The role of mitral TEER in advanced heart failure

Innovations in aortic valves

11 Sep 2025 – From PCR Rio Valves 2025

Discover the latest innovations in aortic valve technology in this comprehensive session. Explore initial clinical experiences with new self-expandable valves in small annuli, mid-term durability data of novel prostheses, and cutting-edge developments such as silver nanoparticle-coated valves and vascular protection implantable systems, providing a forward-looking perspective...

TAVI and structural imaging

11 Sep 2025 – From PCR Rio Valves 2025

This session addresses the critical role of structural imaging in TAVI procedures. Gain valuable knowledge on multimodal imaging approaches in TAVI-in-TAVI cases, complex paravalvular leak management, and unique complications after surgical valve replacement. The session also includes case studies highlighting combined treatments and challenges in severe...

Clinical cases

29 Sep 2025 – From PCR Gulf Valves 2025

This session presents challenging clinical cases focusing on post-TAVI paravalvular leakage and the percutaneous closure of paravalvular leaks following surgically implanted Intuity valves. Gain valuable insights into complex management strategies and procedural techniques addressing these complications.

Mastering mitral and tricuspid TEER: clinical strategies in patients with complex anatomy

17 Nov 2025 – From PCR London Valves 2025

Find out more about advanced mitral and tricuspid TEER techniques for patients with challenging anatomy. This PCR London Valves 2025 session highlights real-world approaches from the Asia Pacific region, including consensus recommendations from the Asian Pacific Society of Cardiology, strategies for simultaneous mitral TEER and left...

Mastering mitral and tricuspid TEER: clinical strategies in patients with complex anatomy

Meet with Myval THV series with real-world case-based learning

17 Nov 2025 – From PCR London Valves 2025

Discover the latest insights from the Myval THV series in this session from PCR London Valves 2025. Through real-world, case-based learning, the session explores lifetime management strategies for TAVI patients, the clinical relevance of intermediate and extra-large valve sizing, and the impact of foreshortening on accurate...

Meet with Myval THV series with real-world case-based learning

Align for the future with next gen Myval transcatheter heart valve series

16 Nov 2025 – From PCR London Valves 2025

Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...

Align for the future with next gen Myval transcatheter heart valve series

Mitral regurgitation: from guidelines to clinical practice

16 Nov 2025 – From PCR London Valves 2025

This LIVE case symposium brings mitral regurgitation guidelines into real clinical practice. Through step-by-step patient demonstrations and insightful discussion, the session explores how recommendations guide decision-making in ventricular and atrial secondary MR, how the heart team tailors therapy to individual anatomy and comorbidities, and how device iterations...

Mitral regurgitation: from guidelines to clinical practice

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

18 Nov 2025 – From PCR London Valves 2025

This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

Cracking the tricuspid code "the Bicaval revolution"

16 Nov 2025 – From PCR London Valves 2025

This session decodes the advancement of caval valve therapy with the TricValve system, offering novel solutions for tricuspid regurgitation and right heart failure. It incorporates insights from clinical trials, real-world cases, and guideline integration, detailing imaging techniques and strategies for complex patient management including rescue interventions.

Cracking the tricuspid code 'the Bicaval revolution'

Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice

17 Nov 2025 – From PCR London Valves 2025

Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...

Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice

Open design, confident delivery - How a novel LAA closure device provides predictable outcomes in complex anatomical settings

16 Nov 2025 – From PCR London Valves 2025

This session highlights a novel left atrial appendage (LAA) closure device featuring an open-cage design that delivers predictable clinical and procedural outcomes. It discusses the device's advantages in managing complex anatomical variations and presents implantation techniques across diverse anatomies to improve safety and efficacy.

Open design, confident delivery - How a novel LAA closure device provides predictable outcomes in complex anatomical settings

Day case TAVI - The future standard of care for most TAVI patients

16 Nov 2025 – From PCR London Valves 2025

Examining the UK experience, this session discusses the emerging standard of day case TAVI and its potential application across Europe. It evaluates patient-centered risks and benefits, operational requirements, and the evolving role of clinical valve coordinators to facilitate safe and efficient day case pathways for TAVI...

Day case TAVI - The future standard of care for most TAVI patients

Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device

17 Nov 2025 – From PCR London Valves 2025

Discover the latest advancements in the VitaFlow transcatheter aortic valve implantation (TAVI) device. This session highlights the electronically enabled VitaFlow Liberty system, delivering consistent immediate and mid-term clinical results. Watch real-world demonstrations of complex cases, including heavily calcified aortas and pure aortic regurgitation, and get a...

Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device

Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options

17 Nov 2025 – From PCR London Valves 2025

Watch this PCR London Valves 2025 session to take a deep look at the latest evidence in low-risk aortic stenosis, the durability of contemporary valves, and how anatomy — especially in women and patients with small annuli — shapes long-term strategy.

From index TAVI with Evolut FX+...

Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options

From innovation to intervention: optimising procedural techniques in tricuspid TEER

17 Nov 2025 – From PCR London Valves 2025

Explore advanced strategies for tricuspid TEER in this PCR London Valves 2025 session.

Through real-world cases and interactive simulation, learn how to optimise outcomes in complex tricuspid anatomy, manage challenges posed by pacemaker leads, and enhance procedural efficiency using the TriClip G5 device.

Gain practical insights on clipping...

From innovation to intervention: optimising procedural techniques in tricuspid TEER

Shaping the treatment of mitral regurgitation with the Intrepid transcatheter mitral valve replacement (TMVR) system

17 Nov 2025 – From PCR London Valves 2025

This session presents an in-depth examination of the Intrepid transcatheter mitral valve replacement (TMVR) system, focusing on its role in treating mitral regurgitation. It covers the system's design features, ongoing clinical research, and long-term durability, complemented by detailed analyses of transapical 5-year outcomes and current trial...

Shaping the treatment of mitral regurgitation with the Intrepid transcatheter mitral valve replacement (TMVR) system

Single operator TAVI: where expertise meets consistency

18 Nov 2025 – From PCR London Valves 2025

This session addresses the concept of single operator transcatheter aortic valve implantation (TAVI), emphasizing the integration of expertise with procedural consistency. Follow a discussion on the benefits of simplifying TAVI to a single operator approach facilitated by an electronically enabled delivery system. The session offers a...

Single operator TAVI: where expertise meets consistency

TAVI in 2025: transforming care with the new valvular heart disease guidelines

18 Nov 2025 – From PCR London Valves 2025

This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...

TAVI in 2025: transforming care with the new valvular heart disease guidelines
Didn’t find what you were looking for?